DIN 02547686 — CYCLOPHOSPHAMIDE FOR INJECTION USP 1000 MG
CYCLOPHOSPHAMIDE FOR INJECTION USP is a powder for solution of Cyclophosphamide marketed by STERIMAX INC. The full Cyclophosphamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02547686
- Brand name
- CYCLOPHOSPHAMIDE FOR INJECTION USP
- Active ingredient
- Cyclophosphamide
- Strength
- 1000 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- STERIMAX INC
- Health Canada status
- MARKETED
- Drug class
- Alkylating antineoplastic agent (nitrogen mustard) / immunosuppressant
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cyclophosphamide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02546736 | CYCLOPHOSPHAMIDE FOR INJECTION USP | 1000 MG | POWDER FOR SOLUTION | ANDONE PHARMACEUTICAL INC | MARKETED |
| 02560216 | CYCLOPHOSPHAMIDE FOR INJECTION USP | 1000 MG | POWDER FOR SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02546744 | CYCLOPHOSPHAMIDE FOR INJECTION USP | 2000 MG | POWDER FOR SOLUTION | ANDONE PHARMACEUTICAL INC | MARKETED |
| 02547694 | CYCLOPHOSPHAMIDE FOR INJECTION USP | 2000 MG | POWDER FOR SOLUTION | STERIMAX INC | MARKETED |
| 02560224 | CYCLOPHOSPHAMIDE FOR INJECTION USP | 2000 MG | POWDER FOR SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02241799 | PROCYTOX | 1000 MG | POWDER FOR SOLUTION | BAXTER CORPORATION | MARKETED |
| 02241797 | PROCYTOX | 200 MG | POWDER FOR SOLUTION | BAXTER CORPORATION | MARKETED |
| 02241800 | PROCYTOX | 2000 MG | POWDER FOR SOLUTION | BAXTER CORPORATION | MARKETED |
| 02241795 | PROCYTOX | 25 MG | TABLET | BAXTER CORPORATION | MARKETED |
| 02241796 | PROCYTOX | 50 MG | TABLET | BAXTER CORPORATION | MARKETED |
| 02241798 | PROCYTOX | 500 MG | POWDER FOR SOLUTION | BAXTER CORPORATION | MARKETED |